Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,029 | 1,249 | 97.6% |
| Education | $451.83 | 14 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,992 | 126 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,418 | 85 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,284 | 90 | $0 (2024) |
| Astellas Pharma US Inc | $1,170 | 54 | $0 (2023) |
| PFIZER INC. | $1,149 | 96 | $0 (2024) |
| Lilly USA, LLC | $1,030 | 91 | $0 (2024) |
| Merck Sharp & Dohme LLC | $948.26 | 78 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $926.02 | 65 | $0 (2023) |
| Amgen Inc. | $871.96 | 55 | $0 (2024) |
| ABBVIE INC. | $704.72 | 53 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,217 | 134 | AstraZeneca Pharmaceuticals LP ($217.45) |
| 2023 | $2,239 | 142 | GlaxoSmithKline, LLC. ($303.34) |
| 2022 | $2,201 | 135 | Novo Nordisk Inc ($412.92) |
| 2021 | $2,109 | 142 | AbbVie Inc. ($239.74) |
| 2020 | $2,083 | 147 | Novo Nordisk Inc ($350.20) |
| 2019 | $2,466 | 196 | Astellas Pharma US Inc ($315.63) |
| 2018 | $2,483 | 165 | Astellas Pharma US Inc ($438.28) |
| 2017 | $2,682 | 202 | AstraZeneca Pharmaceuticals LP ($301.74) |
All Payment Transactions
1,263 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $35.84 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $37.63 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Hematology | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $19.22 | General |
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,510 | 6,373 | $645,206 | $171,526 |
| 2022 | 36 | 3,940 | 6,852 | $525,908 | $188,811 |
| 2021 | 31 | 3,580 | 6,683 | $525,864 | $190,393 |
| 2020 | 32 | 4,313 | 7,086 | $532,988 | $170,287 |
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 950 | $207,030 | $72,380 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 227 | 227 | $29,510 | $27,332 | 92.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 115 | $16,960 | $7,078 | 41.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 298 | 675 | $79,899 | $6,968 | 8.7% |
| 83721 | Ldl cholesterol level | Office | 2023 | 293 | 640 | $46,672 | $6,537 | 14.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 307 | 737 | $22,110 | $6,142 | 27.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 68 | 68 | $5,744 | $5,133 | 89.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 291 | 650 | $43,850 | $4,925 | 11.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 29 | $9,495 | $4,457 | 46.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 229 | 229 | $6,278 | $3,852 | 61.4% |
| 83718 | Hdl cholesterol level | Office | 2023 | 189 | 361 | $25,086 | $2,869 | 11.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 135 | 173 | $23,959 | $2,848 | 11.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 14 | $5,626 | $2,708 | 48.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 125 | 270 | $28,648 | $2,545 | 8.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 125 | 125 | $2,500 | $2,106 | 84.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $1,815 | $1,733 | 95.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 72 | 72 | $11,277 | $1,324 | 11.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 90 | 94 | $13,736 | $1,220 | 8.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 133 | 213 | $17,489 | $1,200 | 6.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,645 | $1,106 | 23.8% |
| 84478 | Triglycerides level | Office | 2023 | 105 | 193 | $6,092 | $1,087 | 17.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 133 | 213 | $9,108 | $1,067 | 11.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 16 | $2,800 | $979.61 | 35.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 25 | 28 | $2,800 | $969.36 | 34.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 55 | $1,900 | $616.37 | 32.4% |
About Dr. Charles Gebhardt, M.D
Dr. Charles Gebhardt, M.D is a Internal Medicine healthcare provider based in Albany, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407842859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Gebhardt, M.D has received a total of $18,480 in payments from pharmaceutical and medical device companies, with $2,217 received in 2024. These payments were reported across 1,263 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($18,029).
As a Medicare-enrolled provider, Gebhardt has provided services to 15,343 Medicare beneficiaries, totaling 26,994 services with total Medicare billing of $721,017. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Albany, GA
- Active Since 09/21/2005
- Last Updated 07/13/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1407842859
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,054
- FARXIGA (Drug) $953.98
- ELIQUIS (Drug) $917.38
- Ozempic (Drug) $787.56
- JARDIANCE (Drug) $679.19
- Kerendia (Drug) $565.87
- MYRBETRIQ (Drug) $560.30
- XARELTO (Drug) $489.85
- JANUVIA (Drug) $478.92
- Livalo (Drug) $425.09
- Dexcom G6 Transmitter (Medical Supply) $423.90
- Saxenda (Drug) $385.38
- ENTRESTO (Drug) $365.88
- Rybelsus (Drug) $362.50
- TRULICITY (Drug) $320.57
- BELSOMRA (Drug) $306.40
- Aimovig (Biological) $287.75
- UBRELVY (Drug) $258.44
- VRAYLAR (Drug) $255.22
- XIFAXAN (Drug) $241.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Albany
Dr. Scott Beegle, M.d, M.D
Internal Medicine — Payments: $1.9M
Frank Cortazar, Md, MD
Internal Medicine — Payments: $225,694
Jill Braverman-Panza, Md, MD
Internal Medicine — Payments: $176,760
Ann Michalek, Md, MD
Internal Medicine — Payments: $79,945
Dr. Nathaniel Steiger, M.d, M.D
Internal Medicine — Payments: $28,637
Mandeep Sidhu, M.d.-M.b.a, M.D.-M.B.A
Internal Medicine — Payments: $21,249